Patent ID: 7468367
Filing Date: 2008-12-23
Classification: A61P,C07D

Abstract:
1. A compound of formula (I): wherein: R represents an optionally substituted (C Y represents hydrogen or an optionally substituted (C Het represents an optionally substituted 5- or 6-membered heteroaryl group containing up to 3 heteroatoms selected from N, O, and S, or an optionally substituted bicyclic heteroaryl group containing up to 3 heteroatoms selected from N, O and S; Ar represents a phenyl, thienyl, pyrrolyl, oxazolyl, thiazolyl, oxadiazolyl, thiadiazolyl, pyridyl, triazolyl, triazinyl, pyridazinyl, pyrimidinyl, isothiazolyl, isoxazolyl, pyrazinyl pyrazolyl, naphthyl, quinolinyl, napththyridinyl, benzimidazolyl, benzoxazolyl, isoquinolinyl, quinoxalinyl or quinazolinyl group, wherein said group is optionally substituted and is substituted by R R wherein the substituents for the optionally substituted R, Y, Het, Ar, and R wherein each of R or wherein when the substituent is R and wherein, in groups Ar and Het, substituents positioned ortho to each other are optionally linked to from a fused ring, or a pharmaceutically acceptable salt thereof, provided the compound is not N-[2-(7-chloro-quinolin-4-ylamino)ethyl]-N-methyl-phthalamic acid; or N-methyl-n-[2-napthalen-2-ylaminoethyl]benzamide.